| Not Yet Recruiting | Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SO NCT07225972 | New York Medical College | Phase 3 |
| Not Yet Recruiting | ID-ENTITY Trial- Evaluating Serial T-ID Monitoring NCT07393594 | Transplant Genomics, Inc. | — |
| Recruiting | Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infec NCT07235683 | University Health Network, Toronto | Phase 4 |
| Not Yet Recruiting | VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol NCT07286461 | University of Rome Tor Vergata | — |
| Recruiting | CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients NCT07096453 | University of Minnesota | Phase 1 / Phase 2 |
| Not Yet Recruiting | Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia NCT06971913 | Peking University People's Hospital | Phase 2 |
| Recruiting | Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing NCT06812598 | The First Affiliated Hospital of Soochow University | N/A |
| Recruiting | CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT NCT06453460 | University of California, Irvine | Phase 2 |
| Recruiting | Expansion of Virus-Specific Lymphocytes for Cell Therapy NCT06011486 | Hospital Israelita Albert Einstein | Phase 1 |
| Unknown | Letermovir (LMV) Prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients With CMV Seroposit NCT06211543 | Grupo Espanol de trasplantes hematopoyeticos y terapia celular | — |
| Completed | Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients NCT06034925 | Medical University of South Carolina | Phase 4 |
| Unknown | Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease NCT05969743 | Rabin Medical Center | Phase 2 |
| Active Not Recruiting | De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Rec NCT06001320 | Virginia Commonwealth University | Phase 3 |
| Completed | Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing Colonoscopy NCT07419204 | Gazi University | — |
| Terminated | A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficien NCT04840199 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Recruiting | Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy NCT04056533 | Instituto de Investigación Marqués de Valdecilla | Phase 2 |
| Completed | Letermovir for CMV Prevention After Lung Transplantation NCT05041426 | Fernanda P Silveira, MD, MS | Phase 2 |
| Unknown | Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy NCT04280380 | Fundación de investigación HM | — |
| Unknown | Effect of Atorvastatin on Subclinical Atherosclerosis NCT04101136 | Dr Cipto Mangunkusumo General Hospital | N/A |
| Completed | A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection NCT04017962 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals NCT04392297 | The Republican Research and Practical Center for Epidemiology and Microbiology | — |
| Completed | CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients NCT03924219 | Vanderbilt University Medical Center | — |
| Completed | Cytomegalovirus Shedding Characteristics in Pregnant Women NCT04021628 | St George's, University of London | — |
| Terminated | Clinical Evaluation of the QuantiFERON CMV Assay NCT03502161 | QIAGEN Gaithersburg, Inc | — |
| Active Not Recruiting | Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants NCT03107871 | Albert Park | Phase 2 |
| Unknown | Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV NCT03858907 | University of Sao Paulo General Hospital | — |
| Terminated | Evaluating the Clinical Utility of the T-SPOT.CMV Assay for the Prediction of CMV Reactivation Among Pediatric NCT03570411 | St. Jude Children's Research Hospital | — |
| Completed | Detection of Cytomegalovirus Virus in Neonates NCT03251261 | Meridian Bioscience, Inc. | — |
| Completed | Search Cytomegalovirus in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota T NCT02694484 | University Hospital, Limoges | N/A |
| Completed | Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) NCT01945814 | Catherine Bollard | Phase 1 |
| Completed | Cytotoxic T Cells to Prevent Virus Infections NCT01923766 | Children's National Research Institute | Phase 1 |
| Completed | A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recip NCT01769170 | Jazz Pharmaceuticals | Phase 3 |
| Recruiting | The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Know NCT01011712 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Does Normal Brain Imaging Predict Normal Neurodevelopmental Outcome in Fetuses With Proven Cytomegalovirus Inf NCT00872703 | Wolfson Medical Center | — |